Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Open accessThe DOI matches its Crossref record; 373 of the 378 references it cites were found in a registry or an index; 122 of the 287 sources its claims cite were checked for support.
Abstract
Depression is a major health problem with a high prevalence and a heavy socioeconomic burden in western societies. It is associated with atrophy and impaired functioning of cortico-limbic regions involved in mood and emotion regulation. It has been suggested that alterations in neurotrophins underlie impaired neuroplasticity, which may be causally related to the development and course of depression. Accordingly, mounting evidence suggests that antidepressant treatment may exert its beneficial effects by enhancing trophic signaling on neuronal and synaptic plasticity. However, current antidepressants still show a delayed onset of action, as well as lack of efficacy. Hence, a deeper understanding of the molecular and cellular mechanisms involved in the pathophysiology of depression, as well as in the action of antidepressants, might provide further insight to drive the development of novel fast-acting and more effective therapies. Here, we summarize the current literature on the involvement of neurotrophic factors in the pathophysiology and treatment of depression. Further, we advocate that future development of antidepressants should be based on the neurotrophin theory.
Overview
CoChat Summary
## TL;DR
This is a narrative review arguing that depression is closely linked to disrupted neuroplasticity and altered neurotrophic signaling, especially in cortico-limbic circuits such as the hippocampus, prefrontal cortex, amygdala, and ventral striatum. The authors conclude that antidepressant development should increasingly target neurotrophin pathways, especially BDNF/TrkB, to achieve faster and more effective treatments.
## Key findings
- Depression is associated with structural and functional changes in mood-related brain regions, including reduced hippocampal volume, reduced size of multiple PFC areas, altered amygdala activity, and impaired ventral striatal reward processing.
- The paper states that serum BDNF is “overall lower in depressed patients” in a meta-analysis, and that this was “confirmed by two other meta-analytic efforts”; however, it also says serum BDNF is not a reliable biomarker because of assay variability and unclear relation to brain BDNF.
- Multiple growth factors are described as altered in MDD and linked to plasticity: FGF1/FGF2 are reported lower in dorsolateral PFC and ACC, VEGF data are described as conflicting in plasma but relevant to SSRI-induced neurogenesis, and IGF-1 is reported as often higher in serum of depressed patients and reduced with effective antidepressant treatment.
- Antidepressant and stimulation treatments are summarized as having plasticity-related effects, including increased hippocampal volume after 3 years of medication, increased hippocampal volume after ECT, and increased progenitor/dividing cells in dentate gyrus in post-mortem brains treated with nortriptyline and clomipramine.
## Methods
- Narrative review of the literature, explicitly stating that it “summarize[s] the current literature” on neurotrophic factors and neuroplasticity pathways in depression and treatment.
- No original sample, cohort, or experimental dataset is reported in the text provided; instead, the paper synthesizes findings from human imaging, post-mortem studies, meta-analyses, and animal/preclinical studies.
- Main analysis is qualitative synthesis across brain regions, neuroplasticity mechanisms, growth factors, and therapeutic interventions, with conclusions drawn from the accumulated literature rather than a new statistical analysis.
## Limitations
- The paper itself notes that much of the human evidence on neuroplasticity is indirect because of “methodological limitations” and “ethical constraints.”
- It states that several peripheral biomarkers are hard to interpret because there is “no evidence that serum BDNF is related to brain BDNF and neuroplasticity,” and similarly that blood levels of other neurotrophins may not reflect brain levels.
- Evident from the text: this is a non-exhaustive narrative review, so the conclusions depend on the cited literature rather than a systematic search or meta-analysis by the authors.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
100 Valid · 5 Not valid · 78 Not checked · 14 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Although these data and other (Baquet et al. 2004) indicate a temperate effect of BDNF in the maintenance of the cellular architecture of the adult brain, most of the studies evidenced its central role in neuronal plasticity.”
§ Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression > Neurotrophins and other growth factors > Brain-derived neurotrophic factor or BDNF
What the sources say
- Disputedcites Baquet et al. 2004 matched to “Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor” (2004) sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says cortical BDNF has a major role in medium spiny neuron dendritic structure, contrary to describing its effect on cellular architecture as temperate. The Discussion (page unavailable) also reports substantial changes in soma, dendrite, and spine morphology, while noting that neuron survival was relatively unaffected at younger ages. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Interestingly, it has been shown that BDNF expression was increased in post-mortem brains of depressed patients treated with antidepressant drugs as compared to non-treated patients (Chen et al. 2001; Dunham et al. 2009).”
§ Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression > Neurotrophins and other growth factors > Brain-derived neurotrophic factor or BDNF
What the sources say
- Not checked — no full text of the sourcecites Chen et al. 2001 matched to “Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication” (2001) source
- Disputedcites Dunham et al. 2009 matched to “Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains” (2009) sourceExperimental — accuracy not yet measured
The Drug Treatment section acknowledges antidepressant-associated BDNF increases reported in earlier studies, but says this study could not confirm them. The Additional information section reports no significant difference between treated and untreated patients and no trend toward an increase among treated patients with MDD. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Animal studies revealed that chronic stress causes atrophy of apical dendrites of pyramidal neurons in the CA3 region of the hippocampus (Magarinos et al. 1996; Vyas et al. 2002; Watanabe et al. 1992).”
§ Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression > Brain regions and neurocircuits involved in depression: neuroanatomical evidence > Hippocampus
What the sources say
- Supportedcites Magarinos et al. 1996 matched to “Chronic Psychosocial Stress Causes Apical Dendritic Atrophy of Hippocampal CA3 Pyramidal Neurons in Subordinate Tree Shrews” (1996) source
The Discussion reports stress-induced apical dendritic atrophy in hippocampal CA3 pyramidal cells of subordinate tree shrews after 28 days of psychosocial stress, compared with controls. This directly supports the cited animal-study claim; the supplied passage does not specify a page. (LLM, conf=0.94)
- Supportedcites Vyas et al. 2002 matched to “Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons” (2002) source
The Results section, “Effects of chronic immobilization stress on dendritic morphology of hippocampal CA3 pyramidal neurons,” reports significant atrophy of apical dendrites in CA3 pyramidal cells after chronic immobilization stress in rats. No page number is supplied in the passages. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites Watanabe et al. 1992 matched to “Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons” (1992) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“PFC abnormalities observed either in MDD patients or in rodent models are partly corrected by antidepressants.”
§ Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression > Brain regions and neurocircuits involved in depression: neuroanatomical evidence > Prefrontal cortex
What the sources say
- Not checked — no full text of the sourcecites Lyttle et al. 2015 matched to “Repeated fluvoxamine treatment recovers juvenile stress-induced morphological changes and depressive-like behavior in rats” (2015) source
- Partly supportedcites Wang et al. 2015a matched to “The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder” (2015) sourceExperimental — accuracy not yet measured
The Discussion reports that escitalopram reduced abnormally high connectivity strength in the dorsomedial prefrontal cortex of patients with MDD, supporting the patient portion of the claim. It does not report correction of prefrontal cortex abnormalities in rodent models; its discussion of animal studies concerns the hippocampus instead. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Depressed patients show an attenuated activation of the VTA-NAc pathway or the NAc itself when compared to normal patients in fMRI analyses (Epstein et al. 2006; Furman et al. 2011; Pizzagalli et al. 2009; Smoski et al. 2009).”
§ Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression > Brain regions and neurocircuits involved in depression: neuroanatomical evidence > Ventral striatum
What the sources say
- Not checked — no full text of the sourcecites Epstein et al. 2006 matched to “Lack of Ventral Striatal Response to Positive Stimuli in Depressed Versus Normal Subjects” (2006) source
- Partly supportedcites Furman et al. 2011 matched to “Frontostriatal functional connectivity in major depressive disorder” (2011) sourceExperimental — accuracy not yet measured
The Ventral striatum results report attenuated functional connectivity between the ventral striatum and two prefrontal regions in participants with major depressive disorder compared with controls; the Discussion describes the striatal seed as approximating the nucleus accumbens. That supports an alteration in an accumbens-related network, but not attenuated activation of the nucleus accumbens itself or of a VTA–NAc pathway. Page numbers were not available in our copy. (LLM, conf=0.87)
- Supportedcites Pizzagalli et al. 2009 matched to “Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder” (2009) source
The Results (Functional MRI Data) report weaker left nucleus accumbens responses to monetary gains in the MDD group than in healthy comparison subjects. The finding concerns reward outcomes, and the authors caution that the nucleus accumbens difference is preliminary after correction for multiple comparisons. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
127 more claims · 64 with their cited sources checked
Create a free account to see all 197 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 59
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Another candidate gene is brain-derived neurotrophic factor (BDNF) which is involved in neuroplastic changes associated with stress and depression13,14.”
From Methylome-wide change associated with response to electroconvulsive therapy in depressed patients (2021) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In depression, altered epigenetic patterns have been observed in key genes related to neurodevelopment and neurotransmission, including the serotonin transporter gene (SLC6A4) and brain-derived neurotrophic factor (BDNF) (Jiang et al., 2019; Levy et al., 2018).”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Levy et al., 2018
Experimental — accuracy not yet measuredIn the citing paper
“exercise among patients with depression upregulated brain-derived neurotrophic factor (BDNF), which stimulates and mediates neurogenesis and regulates depressive behavior [67], in the hippocampus and cortex, promoted hippocampal neurogenesis, and significantly enhanced synaptic plasticity [68].”
From Systematic review and meta-analysis of the effects of exercise on depression in adolescents (2022) · cites this paper as [67]
In the citing paper
“BDNF has been consistently associated to the therapeutic effect of antidepressant drugs [199,200,201].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression > Future directions: targeting growth factor signaling with synthetic small molecules, focus on the BDNF/TrkB pathway > TrkB antagonists
“To our knowledge, only ANA-12 and cyclotraxin B, both described as selective antagonists for TrkB, have been tested so far.”
§ Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression > Future directions: targeting growth factor signaling with synthetic small molecules, focus on the BDNF/TrkB pathway > TrkB antagonists
“ANA-12 is a selective partial agonist that was first developed by Carzola et al. in 2011 using a structure-based in silico screening (Cazorla et al. 2011).”
Citations
Cites
Items 201–373 of 373
Brain-derived Neurotrophic Factor in Megakaryocytes
Chacón-Fernández, P., Säuberli, K., Colzani, M., Moreau, T., Ghevaert, C., & Barde, Y.-A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.720029 · Cited by 186
Interactions of IGF-1 with the Blood-Brain Barrier in vivo and in situ
Pan, W., & Kastin, A. J. (2000) · Neuroendocrinology · doi:10.1159/000054584 · Cited by 185
Zhang, J.-C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., & Hashimoto, K. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4062-3 · Cited by 183 · cited 2×
“…a lower activity of dorsolateral PFC in resting state analyses of MDD patients (Fitzgerald et al. 2008; Hamilton et al. 2012; Limon et al. 2016; Zhang et al. 2015a; Zhong et al. 2016), meta-analyses of this region during task processing and especially in response to emotional stimuli with a…”
BackgroundAssociation of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide
Youssef, M. M., Underwood, M. D., Huang, Y.-Y., Hsiung, S.-C., Liu, Y., Simpson, N. R., Bakalian, M. J., Rosoklija, G. B., Dwork, A. J., Arango, V., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy008 · Cited by 183 · cited 3×
“…analyses showed that depressed patients also have lower BDNF levels in the anterior cingulate cortex (ACC) and the caudal brainstem compared to non-depressed subjects, providing further evidence implicating low brain BDNF and the BDNF Met allele in major depression risk (Youssef et al. 2018).”
InfluentialNinan, I., Bath, K. G., Dagar, K., Perez-Castro, R., Plummer, M. R., Lee, F. S., & Chao, M. V. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1405-10.2010 · Cited by 180
Yonghua, Z., Kunlin, J., Ou Mao, X., & Greenberg, D. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0515com · Cited by 180
Huang, Y., Coupland, N. J., Lebel, R. M., Carter, R., Seres, P., Wilman, A. H., & Malykhin, N. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.005 · Cited by 179
Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder
Gaughran, F., Payne, J., Sedgwick, P. M., Cotter, D., & Berry, M. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.04.008 · Cited by 178
Sun, Y., Jin, K., Childs, J. T., Xie, L., Mao, X. O., & Greenberg, D. A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.10.016 · Cited by 178
Jacobsen, J. P. R., & Mørk, A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.065 · Cited by 177
Dempsey, R. J., Sailor, K. A., Bowen, K. K., Türeyen, K., & Vemuganti, R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02022.x · Cited by 176
Insulin-Like Growth Factor-I and Central Nervous System Development
Anlar, B., Sullivan, K., & Feldman, E. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978708 · Cited by 175
Amygdala reactivity to emotional faces predicts improvement in major depression
Canli, T., Cooney, R. E., Goldin, P., Shah, M., Sivers, H., Thomason, M. E., Whitfield-Gabrieli, S., Gabrieli, J. D. E., & Gotlib, I. H. (2005) · NeuroReport · doi:10.1097/01.wnr.0000174407.09515.cc · Cited by 174
VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration
Carmeliet, P., & de Almodovar, C. R. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1283-7 · Cited by 173
Xu, H., Chen, Z., He, J., Haimanot, S., Li, X., Dyck, L., & Li, X. (2006) · Hippocampus · doi:10.1002/hipo.20184 · Cited by 173
Dunham, J. S., Deakin, J. F. W., Miyajima, F., Payton, A., & Toro, C. T. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.03.008 · Cited by 172
Zhao, M., Li, D., Shimazu, K., Zhou, Y.-X., Lu, B., & Deng, C.-X. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.019 · Cited by 171
Stewart, C. A., & Reid, I. (2000) · Psychopharmacology · doi:10.1007/s002130050045 · Cited by 169
Antidepressant Effects of Fibroblast Growth Factor-2 in Behavioral and Cellular Models of Depression
Elsayed, M., Banasr, M., Duric, V., Fournier, N. M., Licznerski, P., & Duman, R. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.003 · Cited by 169
BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity
Bath, K. G., Jing, D. Q., Dincheva, I., Neeb, C. C., Pattwell, S. S., Chao, M. V., Lee, F. S., & Ninan, I. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.318 · Cited by 169 · cited 2×
“…efficacy through impaired synaptic plasticity defined by a reduction of theta-burst stimulation-induced LTP as well as impairments in the survival of newborn cells in the hippocampus (Bath et al. 2012; Ninan et al. 2010) and a deficit in synaptic transmission in the PFC (Pattwell et al. 2012).”
BackgroundObrietan, K., Gao, X.-B., & van den Pol, A. N. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.2.1005 · Cited by 167
Wang, L., Xia, M., Li, K., Zeng, Y., Su, Y., Dai, W., Zhang, Q., Jin, Z., Mitchell, P. B., Yu, X., et al. (2015) · Human Brain Mapping · doi:10.1002/hbm.22663 · Cited by 166
Emotion and episodic memory in neuropsychiatric disorders
Dere, E., Pause, B. M., & Pietrowsky, R. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.017 · Cited by 165
Zhong, X., Pu, W., & Yao, S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.005 · Cited by 163 · cited 2×
“…of dorsolateral PFC in resting state analyses of MDD patients (Fitzgerald et al. 2008; Hamilton et al. 2012; Limon et al. 2016; Zhang et al. 2015a; Zhong et al. 2016), meta-analyses of this region during task processing and especially in response to emotional stimuli with a negative valence have…”
BackgroundResultDynamics of the dopaminergic system as a key component to the understanding of depression
YADID, G., & FRIEDMAN, A. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00913-8 · Cited by 162
Neural response to pleasant stimuli in anhedonia: an fMRI study
Mitterschiffthaler, M. T., Kumari, V., Malhi, G. S., Brown, R. G., Giampietro, V. P., Brammer, M. J., Suckling, J., Poon, L., Simmons, A., Andrew, C., et al. (2003) · NeuroReport · doi:10.1097/00001756-200302100-00003 · Cited by 162
The Fibroblast Growth Factor Family: Neuromodulation of Affective Behavior
Turner, C. A., Watson, S. J., & Akil, H. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.037 · Cited by 160
VEGF as a potential target for therapeutic intervention in depression
Warner‐Schmidt, J. L., & Duman, R. S. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.013 · Cited by 159
The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain
Mudò, G., Bonomo, A., Di Liberto, V., Frinchi, M., Fuxe, K., & Belluardo, N. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0207-z · Cited by 158
Park, S.-E., Dantzer, R., Kelley, K. W., & McCusker, R. H. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-12 · Cited by 158
Nowacka, M. M., & Obuchowicz, E. (2012) · Neuropeptides · doi:10.1016/j.npep.2011.05.005 · Cited by 157
Angelucci, F., Aloe, L., Jiménez-Vasquez, P., & Mathé, A. A. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003468 · Cited by 157
Pattwell, S. S., Bath, K. G., Perez-Castro, R., Lee, F. S., Chao, M. V., & Ninan, I. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5205-11.2012 · Cited by 156
Autry, A. E., Adachi, M., Cheng, P., & Monteggia, L. M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.007 · Cited by 154 · cited 2×
“This conditional knockout of BDNF in the forebrain displayed the same sex-specific incongruity in stress-induced depressive-like behavior (Autry et al. 2009).”
BackgroundDeltheil, T., Guiard, B. P., Cerdan, J., David, D. J., Tanaka, K. F., Repérant, C., Guilloux, J.-P., Coudoré, F., Hen, R., & Gardier, A. M. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.001 · Cited by 153
Schmid, D. A., Yang, T., Ogier, M., Adams, I., Mirakhur, Y., Wang, Q., Massa, S. M., Longo, F. M., & Katz, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0865-11.2012 · Cited by 152
Veeraiah, P., Noronha, J. M., Maitra, S., Bagga, P., Khandelwal, N., Chakravarty, S., Kumar, A., & Patel, A. B. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.024 · Cited by 152 · cited 2×
“These data were supported by a study showing a decrease in both the excitatory and inhibitory neuronal functions in the PFC and a disturbed neurotransmitter homeostasis in the social defeat mouse model of depression (Veeraiah et al. 2014).”
ResultNerve growth factor promotes survival of new neurons in the adult hippocampus
Frielingsdorf, H., Simpson, D. R., Thal, L. J., & Pizzo, D. P. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.015 · Cited by 151
Rai, K. S., Hattiangady, B., & Shetty, A. K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05820.x · Cited by 144
Greene, J., Banasr, M., Lee, B., Warner-Schmidt, J., & Duman, R. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.68 · Cited by 143
Yang, R. J., Mozhui, K., Karlsson, R.-M., Cameron, H. A., Williams, R. W., & Holmes, A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301665 · Cited by 143
Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.067 · Cited by 142 · cited 2×
“It binds to the GDNF-family receptors α1 (GFRα1) activating tyrosine kinase signaling (Sharma et al. 2016).”
BackgroundAmygdala hyperactivation in untreated depressed individuals
Peluso, M. A. M., Glahn, D. C., Matsuo, K., Monkul, E. S., Najt, P., Zamarripa, F., Li, J., Lancaster, J. L., Fox, P. T., Gao, J.-H., et al. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2009.03.006 · Cited by 141
Harrisberger, F., Smieskova, R., Schmidt, A., Lenz, C., Walter, A., Wittfeld, K., Grabe, H. J., Lang, U. E., Fusar-Poli, P., & Borgwardt, S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.017 · Cited by 138
Allen, A. P., Naughton, M., Dowling, J., Walsh, A., Ismail, F., Shorten, G., Scott, L., McLoughlin, D. M., Cryan, J. F., Dinan, T. G., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.033 · Cited by 138
Shirayama, Y., Yang, C., Zhang, J.-C., Ren, Q., Yao, W., & Hashimoto, K. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.09.002 · Cited by 137
Hisaoka, K., Nishida, A., Koda, T., Miyata, M., Zensho, H., Morinobu, S., Ohta, M., & Yamawaki, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00531.x · Cited by 133
A review of fMRI studies during visual emotive processing in major depressive disorder
Jaworska, N., Yang, X.-R., Knott, V., & MacQueen, G. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.885659 · Cited by 133
The Fibroblast Growth Factor System and Mood Disorders
Turner, C. A., Akil, H., Watson, S. J., & Evans, S. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.026 · Cited by 131
VEGF, a Mediator of the Effect of Experience on Hippocampal Neurogenesis
During, M., & Cao, L. (2006) · Current Alzheimer Research · doi:10.2174/156720506775697133 · Cited by 131
Van Bokhoven, P., Oomen, C. A., Hoogendijk, W. J. G., Smit, A. B., Lucassen, P. J., & Spijker, S. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07668.x · Cited by 129
CHEN, Y., AI, Y., SLEVIN, J., MALEY, B., & GASH, D. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.010 · Cited by 126
Antidepressant-like effects of intracerebroventricular FGF2 in rats
Turner, C. A., Gula, E. L., Taylor, L. P., Watson, S. J., & Akil, H. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.088 · Cited by 125
Alderman, B. L., Olson, R. L., Brush, C. J., & Shors, T. J. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.225 · Cited by 125 · cited 1×
“A recent study showed an increase in synchronous neuronal responses during a task that requires an upregulation of cognitive control when exercise was combined with meditation (Alderman et al. 2016).”
BackgroundRantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020567 · Cited by 124
Païzanis, E., Renoir, T., Lelievre, V., Saurini, F., Melfort, M., Gabriel, C., Barden, N., Mocaër, E., Hamon, M., & Lanfumey, L. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990514 · Cited by 123 · cited 2×
“These models included transgenic mice (Paizanis et al. 2010), corticosteroneinduced mouse model of depression/anxiety (Zhang et al.”
BackgroundSelf-citationDuman, C. H., Schlesinger, L., Terwilliger, R., Russell, D. S., Newton, S. S., & Duman, R. S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.016 · Cited by 123
Induction of LTP in the human auditory cortex by sensory stimulation
Clapp, W. C., Kirk, I. J., Hamm, J. P., Shepherd, D., & Teyler, T. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04293.x · Cited by 122
Cao, X., Liu, Z., Xu, C., Li, J., Gao, Q., Sun, N., Xu, Y., Ren, Y., Yang, C., & Zhang, K. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.002 · Cited by 118
Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures
Khaibullina, A. A., Rosenstein, J. M., & Krum, J. M. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2003.09.022 · Cited by 114
Nordanskog, P., Larsson, M. R., Larsson, E. ‐., & Johanson, A. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12150 · Cited by 114
Reduced amygdala volume in newly admitted psychiatric in-patients with unipolar major depression
Kronenberg, G., van Elst, L. T., Regen, F., Deuschle, M., Heuser, I., & Colla, M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.03.007 · Cited by 112
Giacobbe, P., Mayberg, H. S., & Lozano, A. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.028 · Cited by 112
VEGF and depression: A comprehensive assessment of clinical data
Clark-Raymond, A., & Halaris, A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.04.008 · Cited by 108
Serotonin and neurogenesis in the hippocampal dentate gyrus of adult mammals
Djavadian, R. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1505 · Cited by 108 · cited 1×
“Adult hippocampal neurogenesis was proposed to be required for the therapeutic action of antidepressants (David et al. 2009; Djavadian 2004; Klempin et al. 2013; Sahay and Hen 2007; Santarelli et al. 2003).”
BackgroundMilne, A. M. B., MacQueen, G. M., & Hall, G. B. C. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110004 · Cited by 107
Outgrowth of sympathetic adrenergic neurons in mice treated with a nerve-growth factor (NGF)
Olson, L. (1967) · Zeitschrift für Zellforschung und Mikroskopische Anatomie · doi:10.1007/bf02075968 · Cited by 106 · cited 1×
“Nerve growth factor (NGF) is a growth factor first described as a neurite outgrowth factor (Olson 1967).”
BackgroundZou, Y.-F., Ye, D.-Q., Feng, X.-L., Su, H., Pan, F.-M., & Liao, F.-F. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.12.005 · Cited by 104
Mitschelen, M., Yan, H., Farley, J. A., Warrington, J. P., Han, S., Hereñú, C. B., Csiszar, A., Ungvari, Z., Bailey-Downs, L. C., Bass, C. E., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.032 · Cited by 103
Chen, F., Madsen, T. M., Wegener, G., & Nyengaard, J. R. (2010) · Hippocampus · doi:10.1002/hipo.20718 · Cited by 103
Zhang, H., Dong, W., Dang, W., Quan, W., Tian, J., Chen, R., Zhan, S., & Yu, X. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12209 · Cited by 101
Malberg, J. E., Platt, B., Rizzo, S. J. S., Ring, R. H., Lucki, I., Schechter, L. E., & Rosenzweig-Lipson, S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301358 · Cited by 101
Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice
Jang, S.-W., Liu, X., Chan, C. B., France, S. A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., Chang, Q., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011528 · Cited by 101
Cazorla, M., Jouvenceau, A., Rose, C., Guilloux, J.-P., Pilon, C., Dranovsky, A., & Prémont, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009777 · Cited by 99
In vivo imaging of adult human hippocampal neurogenesis: progress, pitfalls and promise
Ho, N. F., Hooker, J. M., Sahay, A., Holt, D. J., & Roffman, J. L. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.8 · Cited by 98
Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients
Zhang, X., Zhang, Z., Xie, C., Xi, G., Zhou, H., Zhang, Y., & Sha, W. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.004 · Cited by 96
Ota, K. T., & Duman, R. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.022 · Cited by 94
Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response
Keers, R., & Uher, R. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-011-0251-x · Cited by 94
The effects of repetitive transcranial magnetic stimulation in the treatment of depression
Fitzgerald, P. B., & Daskalakis, Z. J. (2011) · Expert Review of Medical Devices · doi:10.1586/erd.10.57 · Cited by 93
Schloesser, R. J., Orvoen, S., Jimenez, D. V., Hardy, N. F., Maynard, K. R., Sukumar, M., Manji, H. K., Gardier, A. M., David, D. J., & Martinowich, K. (2015) · Brain Stimulation · doi:10.1016/j.brs.2015.05.011 · Cited by 93
Disorders of memory and plasticity in psychiatric disease
Pittenger, C. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.4/cpittenger · Cited by 92 · cited 2×
“Beside neurogenesis, numerous studies have also reported that synaptic plasticity was also greatly impaired in stress models of depression (Pittenger 2013).”
BackgroundResultBoulle, F., Massart, R., Stragier, E., Païzanis, E., Zaidan, L., Marday, S., Gabriel, C., Mocaer, E., Mongeau, R., & Lanfumey, L. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.125 · Cited by 91
Self-citationZhu, W., Cheng, S., Xu, G., Ma, M., Zhou, Z., Liu, D., & Liu, X. (2011) · Drug Delivery · doi:10.3109/10717544.2011.557785 · Cited by 90
Pilar-Cuéllar, F., Vidal, R., Díaz, A., Castro, E., dos Anjos, S., Pascual-Brazo, J., Linge, R., Vargas, V., Blanco, H., Martínez-Villayandre, B., et al. (2013) · Neural Plasticity · doi:10.1155/2013/537265 · Cited by 90
Neural correlates during working memory processing in major depressive disorder
Wang, X.-L., Du, M.-Y., Chen, T.-L., Chen, Z.-Q., Huang, X.-Q., Luo, Y., Zhao, Y.-J., Kumar, P., & Gong, Q.-Y. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.011 · Cited by 89
Pallavi, P., Sagar, R., Mehta, M., Sharma, S., Subramanian, A., Shamshi, F., Sengupta, U., Qadri, R., Pandey, R. M., & Mukhopadhyay, A. K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.033 · Cited by 88
ERK1/2 Antagonizes Glycogen Synthase Kinase-3β-induced Apoptosis in Cortical Neurons
Hetman, M., Hsuan, S.-L., Habas, A., Higgins, M. J., & Xia, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111227200 · Cited by 88 · cited 2×
“As such, BNDF has been shown to increase the activity of the mitogen-activated protein kinase (MAPK) cascade promoting survival in neural cell cultures (Hetman et al. 2002).”
BackgroundFalowski, S. M., Sharan, A., Reyes, B. A. S., Sikkema, C., Szot, P., & Van Bockstaele, E. J. (2011) · Neurosurgery · doi:10.1227/neu.0b013e3182237346 · Cited by 87
SIEGLE, G. J., KONECKY, R. O., THASE, M. E., & CARTER, C. S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07105.x · Cited by 87
VEGF is required for dendritogenesis of newly born olfactory bulb interneurons
Licht, T., Eavri, R., Goshen, I., Shlomai, Y., Mizrahi, A., & Keshet, E. (2010) · Development · doi:10.1242/dev.039636 · Cited by 86
Schmuckermair, C., Gaburro, S., Sah, A., Landgraf, R., Sartori, S. B., & Singewald, N. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.21 · Cited by 84
Li, M., Chang, H., & Xiao, X. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.031 · Cited by 82
TrkB inhibition as a therapeutic target for CNS-related disorders
Boulle, F., Kenis, G., Cazorla, M., Hamon, M., Steinbusch, H. W. M., Lanfumey, L., & van den Hove, D. L. A. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.002 · Cited by 80
Self-citationMichel, T. M., Frangou, S., Camara, S., Thiemeyer, D., Jecel, J., Tatschner, T., Zoechling, R., & Grünblatt, E. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.06.001 · Cited by 78
Clapp, W. C., Zaehle, T., Lutz, K., Marcar, V. L., Kirk, I. J., Hamm, J. P., Teyler, T. J., Corballis, M. C., & Jancke, L. (2005) · NeuroReport · doi:10.1097/00001756-200512190-00001 · Cited by 78
Reduced Serum Nerve Growth Factor in Patients With Late-Life Depression
Diniz, B. S., Teixeira, A. L., Machado‐Vieira, R., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.014 · Cited by 78
Pechnick, R. N., Zonis, S., Wawrowsky, K., Cosgayon, R., Farrokhi, C., Lacayo, L., & Chesnokova, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027290 · Cited by 78 · cited 5×
“Chronic imipramine and desipramine treatment increased cell proliferation in the SGZ (Pechnick et al. 2011; Santarelli et al. 2003; Schiavon et al. 2010).”
BackgroundInfluentialThe requirement of BDNF for hippocampal synaptic plasticity is experience‐dependent
Aarse, J., Herlitze, S., & Manahan‐Vaughan, D. (2016) · Hippocampus · doi:10.1002/hipo.22555 · Cited by 74
Cardenas-Aguayo, M. D. C., Kazim, S. F., Grundke-Iqbal, I., & Iqbal, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053596 · Cited by 73
Circulating Glial-derived neurotrophic factor is reduced in late-life depression
Diniz, B. S., Teixeira, A. L., de Miranda, A. S., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.007 · Cited by 73
Settell, M. L., Testini, P., Cho, S., Lee, J. H., Blaha, C. D., Jo, H. J., Lee, K. H., & Min, H.-K. P. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00104 · Cited by 72 · cited 1×
“Deep brain stimulation (DBS) of the NAc has been shown to influence the functionality of efferent projections of the NAc to the hippocampus (Settell et al. 2017).”
BackgroundJiang, P., Dang, R.-L., Li, H.-D., Zhang, L.-H., Zhu, W.-Y., Xue, Y., & Tang, M.-M. (2014) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2014/729827 · Cited by 70 · cited 1×
“In preclinical studies, swimming showed antidepressant-like effects on anhedonia in stressed rodents along with a normalization of a stress-induced BDNFmRNA expression decrease (Jiang et al. 2014).”
BackgroundBramham, C. R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)63025-8 · Cited by 69 · cited 1×
“This was in agreement with data that showed that BDNF infusion in the rat hippocampus induced LTP and triggered synaptic strengthening (Bramham 2007; Ying et al. 2002).”
ResultHan, J., Pollak, J., Yang, T., Siddiqui, M. R., Doyle, K. P., Taravosh-Lahn, K., Cekanaviciute, E., Han, A., Goodman, J. Z., Jones, B., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.641878 · Cited by 69
Zhang, Y., Mao, R.-R., Chen, Z.-F., Tian, M., Tong, D.-L., Gao, Z.-R., Huang, M., Li, X., Xu, X., Zhou, W.-H., et al. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-11 · Cited by 69 · cited 1×
“These models included transgenic mice (Paizanis et al. 2010), corticosteroneinduced mouse model of depression/anxiety (Zhang et al. 2014b), or rats subjected to chronic mild stress (Morais et al. 2017 and see Anacker and Hen 2017 for a review).”
Possible contribution of IGF-1 to depressive disorder
Szczęsny, E., Ślusarczyk, J., Głombik, K., Budziszewska, B., Kubera, M., Lasoń, W., & Basta-Kaim, A. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71523-8 · Cited by 68 · cited 2×
“IGF-1 has been designated as a potential therapeutic target for neurodegenerative diseases such asMDD (Szczesny et al. 2013).”
BackgroundThe fibroblast growth factor system is downregulated following social defeat
Turner, C. A., Calvo, N., Frost, D. O., Akil, H., & Watson, S. J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.041 · Cited by 68
Qian, M. D., Zhang, J., Tan, X.-Y., Wood, A., Gill, D., & Cho, S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1118-06.2006 · Cited by 67
Tsai, T.-H., Chen, S.-L., Chiang, Y.-H., Lin, S.-Z., Ma, H.-I., Kuo, S.-W., & Tsao, Y.-P. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7505 · Cited by 67
Vassilopoulou, K., Papathanasiou, M. A., Michopoulos, I., Boufidou, F., Oulis, P., Kelekis, N., Rizos, E. N., Nikolaou, C. C., Pantelis, C., Velakoulis, D., et al. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.09.003 · Cited by 66
Evidence for Impaired Neocortical Synaptic Plasticity in Bipolar II Disorder
Elvsåshagen, T., Moberget, T., Bøen, E., Boye, B., Englin, N. O. A., Pedersen, P. Ø., Andreassen, O. A., Dietrichs, E., Malt, U. F., & Andersson, S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.026 · Cited by 64
Friedman, A., Friedman, Y., Dremencov, E., & Yadid, G. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9016-8 · Cited by 64 · cited 1×
“In this respect, the NAc and the VTAmay play a role in mediating the anhedonic symptoms of depression (Nestler and Carlezon Jr. 2006; Russo and Nestler 2013; Yadid and Friedman 2008).”
BackgroundIGF-I in major depression and antidepressant treatment response
Kopczak, A., Stalla, G. K., Uhr, M., Lucae, S., Hennings, J., Ising, M., Holsboer, F., & Kloiber, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.12.013 · Cited by 63
Limon, A., Mamdani, F., Hjelm, B. E., Vawter, M. P., & Sequeira, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.010 · Cited by 63
Retinal dysfunction of contrast processing in major depression also apparent in cortical activity
Bubl, E., Kern, E., Ebert, D., Riedel, A., van Elst, L. T., & Bach, M. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0573-x · Cited by 62
Brain anatomy of major depression II. Focus on amygdala
Bellani, M., Baiano, M., & Brambilla, P. (2011) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796011000096 · Cited by 62 · cited 2×
“…either an increase (Frodl et al. 2003; Lange and Irle 2004; Vassilopoulou et al. 2013) or a decrease in amygdalar volume in depressed patients (Bellani et al. 2011; Kronenberg et al. 2009; Lorenzetti et al. 2009), most of the functional MRI (fMRI) studies showed an increased activity of the…”
BackgroundAntidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission
Hoshaw, B. A., Hill, T. I., Crowley, J. J., Malberg, J. E., Khawaja, X., Rosenzweig-Lipson, S., Schechter, L. E., & Lucki, I. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.023 · Cited by 60
7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice
Bollen, E., Vanmierlo, T., Akkerman, S., Wouters, C., Steinbusch, H. M. W., & Prickaerts, J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.09.029 · Cited by 60
Self-citationLiu, X., Chan, C.-B., Qi, Q., Xiao, G., Luo, H. R., He, X., & Ye, K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301099x · Cited by 60
Kron, M., Lang, M., Adams, I. T., Sceniak, M., Longo, F., & Katz, D. M. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016030 · Cited by 59
Fronto-limbic microstructure and structural connectivity in remission from major depression
Arnold, J., Zwiers, M. P., Fitzgerald, D. A., van Eijndhoven, P., Becker, E. S., Rinck, M., Fernández, G., Speckens, A. E. M., & Tendolkar, I. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.07.010 · Cited by 59 · cited 2×
“…using diffusion tensor imaging or MRI, abnormal microstructure and connectivity of the amygdala and the medial prefrontal cortex (PFC) patients (Arnold et al. 2012) as well as reduced functional coupling between the amygdala and the supragenual PFC (Matthews et al. 2008) were reported in…”
BackgroundMethodMa, M., Ren, Q., Yang, C., Zhang, J.-C., Yao, W., Dong, C., Ohgi, Y., Futamura, T., & Hashimoto, K. (2016) · Scientific Reports · doi:10.1038/srep39209 · Cited by 59
Chen, D., Brahimi, F., Angell, Y., Li, Y.-C., Moscowicz, J., Saragovi, H. U., & Burgess, K. (2009) · ACS Chemical Biology · doi:10.1021/cb9001415 · Cited by 56
Werner, S., Unsicker, K., & von Bohlen und Halbach, O. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22680 · Cited by 56
Morais, M., Patrício, P., Mateus-Pinheiro, A., Alves, N. D., Machado-Santos, A. R., Correia, J. S., Pereira, J., Pinto, L., Sousa, N., & Bessa, J. M. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.120 · Cited by 56 · cited 1×
“These models included transgenic mice (Paizanis et al. 2010), corticosteroneinduced mouse model of depression/anxiety (Zhang et al. 2014b), or rats subjected to chronic mild stress (Morais et al. 2017 and see Anacker and Hen 2017 for a review).”
BackgroundDeltheil, T., Tanaka, K., Reperant, C., Hen, R., David, D. J., & Gardier, A. M. (2009) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000017 · Cited by 54
Nakamura, K. M., Ito, M., Liu, Y., Seki, T., Suzuki, T., & Arai, H. (2012) · Brain Research · doi:10.1016/j.brainres.2012.10.052 · Cited by 51
Sirianni, R. W., Olausson, P., Chiu, A. S., Taylor, J. R., & Saltzman, W. M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.041 · Cited by 51
Yau, S.-Y., Li, A., Zhang, E.-D., Christie, B. R., Xu, A., Lee, T. M. C., & So, K.-F. (2014) · Cell Transplantation · doi:10.3727/096368914x678490 · Cited by 50
Bot, M., Milaneschi, Y., Penninx, B. W. J. H., & Drent, M. L. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.028 · Cited by 50 · cited 1×
“serum of depressed patients, which declined during effective antidepressant treatment (Bot et al. 2016; Kopczak et al. 2015; Szczesny et al. 2013).”
BackgroundIntranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression
Paslakis, G., Blum, W. F., & Deuschle, M. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.045 · Cited by 48
A role for nuclear β-catenin in SNRI antidepressant-induced hippocampal cell proliferation
Mostany, R., Valdizán, E. M., & Pazos, A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.012 · Cited by 47
Yan, T., Wang, L., Kuang, W., Xu, J., Li, S., Chen, J., & Yang, Y. (2014) · Asia-Pacific Psychiatry · doi:10.1111/appy.12148 · Cited by 46
(1986) · PubMed · Cited by 45
Radahmadi, M., Hosseini, N., & Alaei, H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.09.045 · Cited by 45 · cited 2×
“A 21-day exercise regimen in rats transiently increased LTP in the DG of the hippocampus (Radahmadi et al. 2016), although recent data suggested that, if motor activity could exert positive effects on cognitive processes, it was under very controlled conditions (D’Arcangelo et al.”
BackgroundTakemoto, T., Ishihara, Y., Ishida, A., & Yamazaki, T. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.06.010 · Cited by 43
Angelucci, F., Aloe, L., Jiménez-Vasquez, P., & Mathé, A. A. (2003) · Neuropeptides · doi:10.1016/s0143-4179(03)00004-0 · Cited by 42 · cited 1×
“In addition, antidepressant exposure increased GDNF release in a rat C6 glioblastoma cell line (Hisaoka et al. 2001), whereas lithium treatment in rats resulted in increased GDNF concentrations in the PFC and occipital cortex but a decrease in the hippocampus (Angelucci et al. 2003b).”
BackgroundNerve growth factor (NGF) has novel antidepressant-like properties in rats
Overstreet, D. H., Fredericks, K., Knapp, D., Breese, G., & McMichael, J. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.11.010 · Cited by 42
Electroconvulsive seizures stimulate the vegf pathway via mTORC1
Elfving, B., & Wegener, G. (2012) · Synapse · doi:10.1002/syn.21518 · Cited by 40
Wong, A. W., Giuffrida, L., Wood, R., Peckham, H., Gonsalvez, D., Murray, S. S., Hughes, R. A., & Xiao, J. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.10.002 · Cited by 39
Blockade of BDNF signaling turns chemically‐induced long‐term potentiation into long‐term depression
Montalbano, A., Baj, G., Papadia, D., Tongiorgi, E., & Sciancalepore, M. (2013) · Hippocampus · doi:10.1002/hipo.22144 · Cited by 39
Liu, Q., Yu, J. M., Mao-Ying, Q.-L., Mi, W.-L., Li, B., Yq, W., Wang, J., & Wu, G. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500485 · Cited by 38
Toki, S., Okamoto, Y., Onoda, K., Matsumoto, T., Yoshimura, S., Kunisato, Y., Okada, G., Shishida, K., Kobayakawa, M., Fukumoto, T., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.021 · Cited by 35
Yasuda, S., Yoshida, M., Yamagata, H., Iwanaga, Y., Suenaga, H., Ishikawa, K., Nakano, M., Okuyama, S., Furukawa, Y., Furukawa, S., et al. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0097-y · Cited by 34
Lim, L. W., Janssen, M. L. F., Kocabıçak, E., & Temel, Y. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.008 · Cited by 33
Park, S. W., Nhu, L. H., Cho, H. Y., Seo, M. K., Lee, C. H., Ly, N. N., Choi, C. M., Lee, B. J., Kim, G.-M., Seol, W., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.010 · Cited by 33 · cited 2×
“Interestingly, in growth medium B27-deprived primary hippocampal cells, BDNF stimulation was able to promote dendritic outgrowth and spine formation (Park et al. 2016) and this neuroplastic effect is probably achieved through intracellular signaling cascades (Cavanaugh et al.”
BackgroundZhao, H., Liu, X., Mao, X.-W., et al. (2004) · PubMed · Cited by 33
Von Bohlen und Halbach, O., Minichiello, L., & Unsicker, K. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02953.x · Cited by 31
Implications of p75NTR for dentate gyrus morphology and hippocampus-related behavior revisited
Dokter, M., Busch, R., Poser, R., Vogt, M. A., von Bohlen und Halbach, V., Gass, P., Unsicker, K., & von Bohlen und Halbach, O. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0737-5 · Cited by 31
Boku, S., Nakagawa, S., Takamura, N., Kato, A., Takebayashi, M., Hisaoka-Nakashima, K., Omiya, Y., Inoue, T., & Kusumi, I. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.011 · Cited by 31
Insulin-like Growth Factors in a clinical setting: Review of IGF-I
Frysak, Z., Schovanek, J., Iacobone, M., & Karasek, D. (2015) · Biomedical Papers · doi:10.5507/bp.2015.041 · Cited by 30
Bruchim-Samuel, M., Lax, E., Gazit, T., Friedman, A., Ahdoot, H. L., Bairachnaya, M., Pinhasov, A., & Yadid, G. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.016 · Cited by 30 · cited 2×
“Furthermore, it appeared that both high- and low-frequency electrical ventromedial PFC stimulations in rat models of depression attenuated depressive-like behavior (Bruchim-Samuel et al. 2016; Lim et al. 2015).”
BackgroundM’Dahoma, S., Barthélemy, S., Tromilin, C., Jeanson, T., Viguier, F., Michot, B., Pezet, S., Hamon, M., & Bourgoin, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.026 · Cited by 29
Treatment With Antidepressants Increases Insulin-Like Growth Factor-I in Cerebrospinal Fluid
Schilling, C., Blum, W. F., Heuser, I., Paslakis, G., Wudy, S. A., & Deuschle, M. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182189d86 · Cited by 29
Schiavon, A. P., Milani, H., Romanini, C. V., Foresti, M. L., de Castro, O. W., Garcia‐Cairasco, N., & de Oliveira, R. M. W. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.052 · Cited by 28
Kim, G. S., Cho, S., Nelson, J. W., Zipfel, G. J., & Han, B. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088962 · Cited by 27
Fried, E. I., & Kievit, R. A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.199 · Cited by 27 · cited 1×
“…suffered from depression for 2 years or who had more than one episode (McKinnon et al. 2009) or evidencing deficit in hippocampal volume deficits in recurrent but not in first episode MDD patients (Schmaal et al. 2016), although this last study gave rise to some debate (Fried and Kievit 2016).”
ResultLyttle, K., Ohmura, Y., Konno, K., Yoshida, T., Izumi, T., Watanabe, M., & Yoshioka, M. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.058 · Cited by 26
Perreault, M., Feng, G., Will, S., Gareski, T., Kubasiak, D., Marquette, K., Vugmeyster, Y., Unger, T. J., Jones, J., Qadri, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062616 · Cited by 26
Boulle, F., Velthuis, H., Koedam, K., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., Gabriel, C., Mocaer, E., Franc, B., Rognan, D., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.003 · Cited by 24
Self-citationChen, Y.-T., Huang, M.-W., Hung, I.-C., Lane, H.-Y., & Hou, C.-J. (2014) · Behavioral and Brain Functions · doi:10.1186/1744-9081-10-36 · Cited by 24
Zung, S., Duran, F., Soeiro‐de‐Souza, M. G., Uchida, R. R., Bottino, C. M. C., Busatto, G. F., & Vallada, H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.97 · Cited by 24
Epidermal growth factor does not cross the blood-brain barrier
Nave, K., Probstmeier, R., & Schachner, M. (1985) · Cell and Tissue Research · doi:10.1007/bf00217193 · Cited by 23
TrkB partial agonists: Potential treatment strategy for major depression
Tsai, S. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.06.019 · Cited by 22
VEGF regulates antidepressant effects of lamotrigine
Sun, R., Li, N., & Li, T. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.010 · Cited by 22
Identification and Characterization of Compounds That Potentiate NT-3-Mediated Trk Receptor Activity
Lewis, M. A., Hunihan, L., Franco, D., Robertson, B., Palmer, J., Laurent, D. R. S., Balasubramanian, B. N., Li, Y., & Westphal, R. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020255 · Cited by 21
Modulation of synaptic plasticity by short-term aerobic exercise in adult mice
D’Arcangelo, G., Triossi, T., Buglione, A., Melchiorri, G., & Tancredi, V. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.058 · Cited by 21
Tendulkar, R. D., Hunter, G. K., Reddy, C. A., Stephans, K. L., Ciezki, J. P., Abdel-Wahab, M., Stephenson, A. J., Klein, E. A., Mahadevan, A., & Kupelian, P. A. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.05.044 · Cited by 20
Liberto, V., Mudo, G., Fuxe, K., & Belluardo, N. (2014) · Current Protein & Peptide Science · doi:10.2174/1389203715666140901112245 · Cited by 19
No Significant Effect of 7,8-Dihydroxyflavone on APP Processing and Alzheimer-Associated Phenotypes
Zhou, W., Li, X., Huang, D., Zhou, W., Li, T., & Song, W. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666141218124243 · Cited by 19 · cited 1×
“2014c), while it did not seem to exert this effect when injected chronically in APP23PS45 transgenic mice (Zhou et al. 2015).”
BackgroundColle, R., Cury, C., Chupin, M., Deflesselle, E., Hardy, P., Nasser, G., Falissard, B., Ducreux, D., Colliot, O., & Corruble, E. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.04.009 · Cited by 18
Angiogenesis in refractory depression: A possible phenotypic target to avoid the blood brain barrier
Yamada, M. K. (2016) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2016.01003 · Cited by 16 · cited 16×
“Chronic stress in rats decreased the expression of VEGF and its receptor in the hippocampus (Heine et al. 2005).”
BackgroundInfluentialTabassum, H., & Frey, J. U. (2013) · Hippocampus · doi:10.1002/hipo.22166 · Cited by 15 · cited 5×
“2017) and that acute swim stress could also led to LTD (Tabassum and Frey 2013).”
BackgroundInfluential
Cited by
Post-stroke depression: A 2020 updated review
Medeiros, G. C., Roy, D., Kontos, N., & Beach, S. R. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.06.011 · Cited by 587
Systematic review and meta-analysis of the effects of exercise on depression in adolescents
Wang, X., Cai, Z.-D., Jiang, W.-T., Fang, Y.-Y., Sun, W.-X., & Wang, X. (2022) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-022-00453-2 · Cited by 169
“In addition, exercise among patients with depression upregulated brain-derived neurotrophic factor (BDNF), which stimulates and mediates neurogenesis and regulates depressive behavior [67], in the hippocampus and cortex, promoted hippocampal neurogenesis, and significantly enhanced synaptic plasticity [68].”
BackgroundSarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle–Brain Axis
Arosio, B., Calvani, R., Ferri, E., Coelho-Junior, H. J., Carandina, A., Campanelli, F., Ghiglieri, V., Marzetti, E., & Picca, A. (2023) · Nutrients · doi:10.3390/nu15081853 · Cited by 165
“BDNF produced by the muscle also regulates myogenesis, muscle regeneration, and satellite cell activation [83,84].”
BackgroundZhao, B., Wu, J., Li, J., Bai, Y., Luo, Y., Ji, B., Xia, B., Liu, Z., Tan, X., Lv, J., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c00196 · Cited by 149
The role of the microbiome in the neurobiology of social behaviour
Sarkar, A., Harty, S., Johnson, K. V. ‐., Moeller, A. H., Carmody, R. N., Lehto, S. M., Erdman, S. E., Dunbar, R. I. M., & Burnet, P. W. J. (2020) · Biological Reviews · doi:10.1111/brv.12603 · Cited by 135
“However, researchers are discovering that the aetiology of depression extends well beyond serotonergic disruption, and there is increasing evidence that clinical depression is a highly heterogeneous disorder with multiple, intertwined aetiologies linked to alterations in brain plasticity and monoamine functions in gen…”
Background
Metadata
- Authors
- Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L.
- Affiliations
- Inserm (FR)
- Maastricht University (NL)
- Corresponding author
- Lanfumey, Laurence
- Venue
- Psychopharmacology
- Published
- 2018-06-30
- Volume
- 235
- Issue
- 8
- Pages
- 2195-2220
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC6061771
- OpenAlex
- W2810237733
- Cited by
- 308
- References
- 378
- Citations by year
- 2026: 18 · 2025: 66 · 2024: 34 · 2023: 47 · 2022: 46 · 2021: 49 · 2020: 34 · 2019: 12 · 2018: 1
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Psychopharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Inserm
- Agence Nationale de la Recherche (2011-BSV-017-01)
- Internationale Stichting Alzheimer Onderzoek (12530)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- depression, neurotrophic factors, neuroplasticity, antidepressants, synaptic plasticity, rapid-acting antidepressants, antidepressant mechanism, depression pathophysiology
- MeSH terms
- Affect, Animals, Antidepressive Agents, Depression, Emotions, Humans, Nerve Growth Factors, Neuronal Plasticity, Signal Transduction, Biomarkers, Treatment Outcome, Brain-Derived Neurotrophic Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-02, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-02 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.